TargetMol
γ-Secretase modulator 11 hydrochloride is a potent, orally active γ-secretase modulator (IC50: 0.029 μM). γ-Secretase modulator 11 hydrochloride significantly reduces brain Aβ42 levels and rescues the cognitive deficits exhibited by AD model mice. γ-Secretase modulator 11 hydrochloride has shown research potential in Alzheimer’s disease.
More Information
Supplier Page
TargetMol
γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].
More Information
Supplier Page
TargetMol
γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].
More Information
Supplier Page
TargetMol
γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].
More Information
Supplier Page
TargetMol
gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.
More Information
Supplier Page
TargetMol
gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.
More Information
Supplier Page
TargetMol
gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.
More Information
Supplier Page
TargetMol
γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.
More Information
Supplier Page
TargetMol
γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.
More Information
Supplier Page
TargetMol
γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.
More Information
Supplier Page
TargetMol
γ-Terpinene is a monoterpene compound with high antioxidant properties suitable for oral consumption. It displays direct radical scavenging abilities and is known to be a potent antinociceptive agent.
More Information
Supplier Page
TargetMol
γ-Terpinene is a monoterpene compound with high antioxidant properties suitable for oral consumption. It displays direct radical scavenging abilities and is known to be a potent antinociceptive agent.
More Information
Supplier Page
TargetMol
(+)-γ-Tocopherol is one of the naturally occurring forms of Vitamin E. It is the most abundant Tocopherol in soybean and corn oils.
More Information
Supplier Page
TargetMol
(+)-γ-Tocopherol is one of the naturally occurring forms of Vitamin E. It is the most abundant Tocopherol in soybean and corn oils.
More Information
Supplier Page
γ-Tocotrienol
1 mL
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
1 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
2 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
5 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
10 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
25 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
50 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ-Tocotrienol
100 mg
| Purity Not Available
TargetMol
gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.
More Information
Supplier Page
γ1-MSH
1 mg
| Purity Not Available
TargetMol
Endogenous melanocortin MC3 receptor agonist (pKi = 7.46) that displays ~ 40-fold selectivity over MC4. Increases the release of extracellular dopamine, which induces grooming and vertical activity (rearing) in rats. Exhibits hypertensive, tachycardic and short-term analgesic activity in vivo.
More Information
Supplier Page
γ1-MSH TFA
5 mg
| Purity Not Available
TargetMol
γ1-MSH TFA is a melanocortin MC3 receptor agonist, with a K i of 34 nM for the rat MC3 receptor. γ1-MSH TFA displays ~40-fold selectivity over MC4 (K i =1318 nM) [1] .
More Information
Supplier Page
γ1-MSH TFA
50 mg
| Purity Not Available
TargetMol
γ1-MSH TFA is a melanocortin MC3 receptor agonist, with a K i of 34 nM for the rat MC3 receptor. γ1-MSH TFA displays ~40-fold selectivity over MC4 (K i =1318 nM) [1] .
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.
More Information
Supplier Page
TargetMol
δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.
More Information
Supplier Page
TargetMol
δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.
More Information
Supplier Page
TargetMol
δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.
More Information
Supplier Page
TargetMol
δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.
More Information
Supplier Page